Back to Search Start Over

United Kingdom,United States : SK bioscience and GSKs adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study; Biologics License Application submitted for SKYCovione(GBP510|GSK adjuvant) in South Korea

Source :
Mena Report. May 4, 2022
Publication Year :
2022

Abstract

Recombinant protein-based GBP510 with GSK pandemic adjuvant demonstrates superior neutralising titres compared to a control vaccine and clinically favourable safety profile SK submits license application to MFDS to support vaccine [...]

Details

Language :
English
ISSN :
22190112
Database :
Gale General OneFile
Journal :
Mena Report
Publication Type :
News
Accession number :
edsgcl.702493689